| REVIEW ARTICLE |
|
| Year : 2022 | Volume
: 11
| Issue : 3 | Page : 79-82 |
|
|
Drug-induced liver injury: A primer for cardiologists
Narendra Singh Choudhary1, Neeraj Saraf1, Vinod Kumar2, Manish Bansal3, Ravi R Kasliwal3
1 Department of Hepatology, Medanta the Medicity, Gurugram, Haryana, India
2 Department of Cardiology, Narayana Multispecialty Hospital, Jaipur, Rajasthan, India
3 Division of Clinical and Preventive Cardiology, Medanta the Medicity, Gurugram, Haryana, India
Correspondence Address:
MD, DM Narendra Singh Choudhary
Department of Hepatology, Medanta the Medicity Hospital, Sector 38, Gurugram, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcpc.jcpc_8_22
|
|
|
Although drug-induced liver injury (DILI) is an uncommon diagnosis, it is an important cause of morbidity and mortality in hepatology practice. A timely diagnosis of DILI is important to stop causative drugs and keeping a high index of suspicion is important. There is no gold standard single test to diagnosed DILI, causality scores help in establishing a diagnosis. DILI presenting as acute liver failure is associated with poor prognosis in natural course. The association of nonalcoholic fatty liver disease with cardiac disease makes it more important to think of DILI in a patient with liver dysfunction. We discuss various aspects of DILI in cardiology context in the current review. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
